Home > SWOT Analysis > BioMimetic Therapeutics (BMTI) SWOT Analysis





BioMimetic Therapeutics (BMTI) SWOT Analysis Profile

BioMimetic Therapeutics, Inc. founded in 1999, develops products used for bone and tissue regeneration. Their products, a bio-active drug-device combination, are specifically geared towards healing musculoskeletal injuries and diseases, including orthopedic, spine, and sports injury applications. The company is headquartered in Franklin, Tennessee. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email